Abstract
In autumn 2004, many Japanese patients with renal failure developed cryptogenic encephalopathy by consuming sugihiratake mushroom, a Japanese delicacy. To elucidate the relationship between the cryptogenic cases and this mushroom, we conducted a multivariate analysis of metabolites in 'Probably Toxic' sugihiratake collected from the area of encephalopathy outbreaks, and 'Probably Safe' sugihiratake collected from unaffected areas using UPLC/ToF MS. The results indicate that the presence of milligram quantities of vitamin D-like compounds per 10 g of dried sugihiratake from the areas of encephalopathy outbreaks. Two hypotheses to induce the encephalopathy are proposed: the found metabolites are (1) vitamin D agonists, which induce acute and severe hypercalcemia and/or hyperammonemia and/or vitamin D toxicity, or (2) vitamin D antagonists, which induce acute and severe hypocalcemia. © 2006 Pharmaceutical Society of Japan.
Author supplied keywords
Cite
CITATION STYLE
Sasaki, H., Akiyama, H., Yoshida, Y., Kondo, K., Amakura, Y., Kasahara, Y., & Maitani, T. (2006). Sugihiratake mushroom (Angel’s Wing Mushroom)-induced cryptogenic encephalopathy may involve vitamin D analogues. Biological and Pharmaceutical Bulletin, 29(12), 2514–2518. https://doi.org/10.1248/bpb.29.2514
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.